Insider Transactions in Q2 2023 at Adaptimmune Therapeutics PLC (ADAP)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2023
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,333
-39.87%
|
$0
$0.92 P/Share
|
|
Jun 01
2023
|
Garry E Menzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
209,931
+50.0%
|
-
|
|
Jun 01
2023
|
Garry E Menzel Director |
BUY
Grant, award, or other acquisition
|
Indirect |
401,293
+50.0%
|
-
|